UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
FORM 8-K
 
CURRENT REPORT
 
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
 
Date of Report (Date of earliest event reported): March 29, 2010
 
CHINA MEDICINE CORPORATION
(Exact name of registrant as specified in Charter)
 
Nevada
000-51379
51-0539830
(State of Incorporation)
(Commission File Number)
 (IRS Employer
Identification No.)

Guangri Tower, Suite 702
No. 8 Siyou South 1st Street
Yuexiu District
Guangzhou, China 510600
(Address of registrant’s principal executive office)
 
(8620) 8739-1718 and (8620) 8737-8212
(Registrant’s telephone number, including area code)
 
Check the appropriate box below in the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
 
o
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

o
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240. 14a-12)

o
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

o
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 
 
 

Item 2.02
Results of Operations and Financial Condition

On March 29, 2010, the registrant issued a press release announcing (i) certain financial results for the fiscal year ended December 31, 2009; and (ii) a conference call to be held by the registrant on Monday, March 29, 2010 at 9:00 a.m. Eastern Time to discuss the results of operations for the year ended December 31, 2009. A copy of the press release is attached hereto as Exhibit 99.1.
 
Item 9.01
Financial Statements and Exhibits

 (d) Exhibits

The exhibits required by this item are listed on the Exhibit Index to this report.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
 
CHINA MEDICINE CORPORATION 
     
 
By:
/s/ Senshan Yang
 
Name:  
Senshan Yang
 
Title:  
Chief Executive Officer

Date:    March 29, 2010

 
 
 

Exhibit Index
 
Exhibit
Number
  
Description
     
99.1
  
Press Release of China Medicine Corporation, dated March 29, 2010